Does the Development of Vaccines Advance Solutions for Tuberculosis?
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human pathogens. The global mortality rate of TB stands at approximately 2 million, while about 8 to 10 million active new cases are documented yearly. It is, therefore, a priority to develop vaccines that will...
Saved in:
Main Authors: | Almatar, Manaf, Makky, Essam A., AlMandeal, Husam, Eker, Emel, Kayar, Begum, Var, Isıl, Koksal, Fatih |
---|---|
Format: | Article |
Language: | English |
Published: |
Bentham Science
2018
|
Subjects: | |
Online Access: | http://umpir.ump.edu.my/id/eprint/23655/1/Does%20the%20Development%20of%20Vaccines%20Advance%20Solutions%20for%20Tuberculosis.pdf http://umpir.ump.edu.my/id/eprint/23655/ https://doi.org/10.2174/1874467212666181126151948 https://doi.org/10.2174/1874467212666181126151948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond
by: Almatar, Manaf, et al.
Published: (2017) -
Novel Compounds Targeting InhA for TB Therapy
by: Almatar, Manaf, et al.
Published: (2018) -
The role of nanoparticles in the inhibition of multidrug-resistant bacteria and biofilms
by: Al Matar, Manaf, et al.
Published: (2018) -
Antimicrobial peptides as an alternative to anti-tuberculosis drugs
by: Almatar, Manaf, et al.
Published: (2018) -
Are There Any Other Compounds Isolated from Dermacoccus spp at All?
by: Almatar, Manaf, et al.
Published: (2017)